NovaBridge Biosciences Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NovaBridge Biosciences share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 102.55K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 102.55K shares derived: 20-F 12 month − 6-K 9 month · filed 2026-04-07 | 347.84K shares 20-F · filed 2026-04-07 |
| 2024-12-31 | 0.00 shares 20-F · filed 2025-04-03 | |
| 2023-12-31 | 280.57K shares 20-F · filed 2025-04-03 | |
| 2022-12-31 | 6.85M shares 20-F · filed 2025-04-03 | |
| 2021-12-31 | 8.23M shares 20-F · filed 2024-04-30 |